Get a Quote

Bosutinib API | CAS 380843-75-4
CAS NO.: 380843-75-4
Chemical Formula: C26H29Cl2N5O3
Molecular Weight: 530.4460
DMF&GMP status: Please contact us for more details.
Description:
Bosutinib interferes with the growth of some cancer cells. Bosutinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myelogenous leukemia (CML). Bosutinib is usually given after other similar medications have been tried without success. Bosutinib may also be used for purposes not listed in this medication guide.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
BOSUTINIB MONOHYDRATETABLET; ORALEQ 100MG BASEBOSULIFWYETH PHARMS INC
BOSUTINIB MONOHYDRATE TABLET; ORAL EQ 500MG BASE BOSULIF WYETH PHARMS INC
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
600200827-Mar-18YYU - 1284
7417148 23-Jan-26     U - 1283
7767678 23-Nov-26 Y Y    
7919625 11-Dec-25   Y
Exclusive Data
Exclusivity Code Exclusivity Expiration
NCE 4-Sep-17
ODE 4-Sep-19